Drug licenses : a new model for pharmaceutical pricing
Year of publication: |
2008
|
---|---|
Authors: | Goldman, Dana P. ; Jena, Anupam B. ; Philipson, Tomas ; Sun, Eric |
Published in: |
Health affairs : at the intersection of health, health care, and policy. - Bethesda, Md. : Project Hope, ISSN 0278-2715, ZDB-ID 632712-6. - Vol. 27.2008, 1, p. 122-129
|
Subject: | Pharmaindustrie | Pharmaceutical industry | Arzneimittel | Pharmaceuticals | Preismanagement | Pricing strategy | Lizenz | Licence | Gesundheitsökonomik | Health economics |
-
Compulsory licenses in the pharmaceutical industry : pricing and R&D strategies
Sarmah, Archita, (2020)
-
Russo, Giuliano, (2014)
-
The economics of alternative payment models for pharmaceuticals
Hlávka, Jakub P., (2021)
- More ...
-
A reexamination of the costs of medical R&D regulation
Philipson, Tomas J., (2012)
-
The value of life in general equilibrium
Jena, Anupam B., (2008)
-
The contributions of improved therapy and earlier detection to cancer survival gains, 1988 - 2000
Sun, Eric, (2010)
- More ...